Immunization by exposure to live virus (SIVmne/HIV-2287) during antiretroviral drug prophylaxis may reduce risk of subsequent viral challenge
在接受抗逆转录病毒药物预防治疗期间，通过接触活病毒（SIVmne/HIV-2287）进行免疫接种，可能降低后续病毒攻击的风险。
期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0240495
Frenkel, Lisa M; Kuller, LaRene; Beck, Ingrid A; Tsai, Che-Chung; Joy, Jaimy P; Mulvania, Thera M; Hu, Shiu-Lok; Montefiori, David C; Anderson, David M
